Authors' recommendations: Nausea and vomiting in pregnancy, also known as morning sickness, is very common in early pregnancy. It is unpleasant, but usually stops by weeks 16 to 20 of pregnancy. Some women get a very severe form of nausea and vomiting called hyperemesis gravidarum, which can be very serious and needs specialist treatment in hospital. There are currently no medications that are specifically licensed to treat nausea and vomiting in pregnancy, although medications licensed for other diseases can be used. Diclectin is a new drug that is designed to specifically treat nausea and vomiting in pregnancy. Diclectin is being studied to see whether it improves nausea and vomiting in pregnancy and that it is safe to use for pregnant women. If diclectin is licensed for use in the UK, it could provide a new treatment for this unpleasant condition where other non-medical remedies have not worked.

Project Status: Completed

Year Published: 2016

URL for published report: http://www.hsric.nihr.ac.uk/topics/diclectin-doxylamine-succinate-and-pyridoxine-hydrochloride-for-the-treatment-of-nausea-and-vomiting-in-pregnancy/

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

Organisation Name: NIHR Horizon Scanning Centre

Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269

Contact Name: c.packer@bham.ac.uk

Contact Email: c.packer@bham.ac.uk

Copyright: NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)